SREBF2 and hepatocellular carcinoma: MeRIP assays further showed that the m6A modification level of SREBF2-AS1 was elevated in HCC cells HepG2, HuH-7, and SNU-398 compared with immortalized liver cells THLE-2 (Fig. 2C and Supplementary Fig. S1B).